Missing/wrong data?
Log in to edit
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
scientific article published in September 2010
Author/s
author: Sirpa Leppä, Mats Jerkeman
Work details
Publication date
September 1, 2010
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.